Clin Res Cardiol (2021)
DOI DOI https://doi.org/10.1007/s00392-021-01843-w

T-cell subset disparity and exhaustion distinguish acute coronary syndromes with intact and ruptured fibrous cap
T. Gerhardt1, Y. Abdelwahed1, G. Nelles1, P. Stapmanns1, C. Allomba1, D. Meteva1, C. Seppelt1, S. Knüppel1, A. Haghikia1, M. Joner2, N. Kränkel1, U. Landmesser1, D. Leistner1
1CC 11: Med. Klinik für Kardiologie, Charité - Universitätsmedizin Berlin, Berlin; 2Deutsches Herzzentrum München, München;

Background: Rupture of atherosclerotic plaque is the most common cause of acute coronary syndrome (ACS with ruptured fibrous cap, RFC-ACS). In about one third of ACS-events, however, the causative acute pathology is plaque erosion, characterized by coronary thrombus formation at a culprit plaque with intact fibrous cap (IFC-ACS). The pathomechanism of this important pathology is largely unknown. Within the translational OPTICO-ACS study program, we recently observed significant enrichment of cytotoxic- and helper T-cells selectively at the culprit lesion site of IFC-ACS, but phenotypical and functional details of the observed T-cell response remain unknown.  

 

Methods and results: In a delicate balance, the principal CD4+ T-helper (TH)-subsets (regulatory T-cells (Tregs, CD127lo,CD25+), TH1- (CXCR3+), TH2- (CCR4+CCR6-), TH17- (CCR4+CCR6+), TH9- (CCR4-CCR6+) and T-follicular helper (TFH, CXCR5+) cells) mediate distinct pro-inflammatory, destabilizing (e.g. TH1, TH17) or anti-inflammatory, protective (e.g. Treg, TH2) effects on coronary atherosclerosis. For in depth characterization of local adaptive immune processes in IFC- and RFC-ACS, we used a novel combination of OCT imaging, catheter-based sample acquisition and flow-cytometry in a preliminary cohort of 17 ACS patients. Pointing to a favorable immune profile in IFC-ACS, we showed markedly elevated Treg/TH1, Treg/TH17 and TH2/TH1 ratios (p ≤0.01), as well as a trend towards local Treg accumulation ((p=0.053) as % total CD4+ T-cells in whole blood aspirated from the culprit lesion site) in IFC-ACS as compared to RFC-ACS. Interestingly, cytotoxic T-cells at the culprit lesion site of IFC-, but not RFC-ACS showed enhanced (p<0.01) expression of exhaustion markers (CD8+PD1+CD57+). In RFC-ACS, in contrast, TH1 and TH17 cells were significantly enriched (p ≤0.03) and we observed selective expansion of a highly differentiated cytotoxic CD8/CD28null-subset with high effector potential despite a replicative senescence. There were no significant differences in the TH9 or TFH subsets and CD4+ memory distribution was comparable among both ACS-causing pathologies.

 

Summary: For the first time, this study presents detailed phenotypic and functional characterization of the CD4+ and CD8+ T-cell response in different pathophysiologies of ACS. Besides the quantitative enrichment of T-cells previously described within IFC-ACS, culprit lesions with intact fibrous cap host a favorable, Treg-dominated adaptive response as compared to a skew towards aggressive T-effector phenotypes in RFC-ACS.


https://dgk.org/kongress_programme/jt2021/aV1328.html